Corient Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Corient Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.26M	Sell	52,212 -637	-1%	-$86.1K	0.01%	707
2026 Q1	$6.3M	Sell	52,849 -1,662	-3%	-$207K	0.01%	776
2025 Q4	$6.65M	Buy	54,511 +15,808	+41%	+$1.81M	0.01%	677
2025 Q3	$3.88M	Sell	38,703 -4,437	-10%	-$400K	0.01%	801
2025 Q2	$3.58M	Sell	43,140 -14,439	-25%	-$1.15M	﹤0.01%	808
2025 Q1	$4.67M	Sell	57,579 -28,167	-33%	-$2.52M	0.01%	704
2024 Q4	$7.46M	Sell	85,746 -20,259	-19%	-$1.96M	0.01%	593
2024 Q3	$10.5M	Sell	106,005 -17,909	-14%	-$1.76M	0.02%	551
2024 Q2	$11.5M	Sell	123,914 -19,481	-14%	-$1.75M	0.02%	499
2024 Q1	$13.6M	Buy	143,395 +17,218	+14%	+$1.6M	0.02%	461
2023 Q4	$11.3M	Buy	126,177 +22,902	+22%	+$1.7M	0.02%	489
2023 Q3	$7.54M	Sell	103,275 -12,259	-11%	-$979K	0.02%	542
2023 Q2	$9.61M	Buy	115,534 +31,735	+38%	+$2.65M	0.02%	482
2023 Q1	$6.39M	Buy	83,799 +81,043	+2,941%	+$6.72M	0.02%	527
2022 Q4	$229K	Buy	+2,756	New	+$223K	﹤0.01%	1442

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Corient Private Wealth's XBI Position: Q2 2026 in Review

Corient Private Wealth reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.2% in Q2 2026, selling an estimated $86.1K and leaving 52,212 shares worth $8.26M. The position accounts for 0.01% of the portfolio, ranked #707.

Corient Private Wealth first reported a position in XBI in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.6M in Q1 2024. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Corient Private Wealth held 52,212 shares of State Street SPDR S&P Biotech ETF worth $8.26M as of Q2 2026.
Corient Private Wealth sold 637 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $86.1K.
State Street SPDR S&P Biotech ETF made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #707 holding.
Corient Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 15 quarters since.
Corient Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $13.6M in Q1 2024.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.